Home › Kleincellige longkanker › Missouri › St. Louis
Kleincellige longkanker klinische studies in St. Louis, MO
13 studies voor Kleincellige longkanker zoeken deelnemers op locaties in en rond St. Louis (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
RekruterenFase 3
- Mercy South, St Louis
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
RekruterenFase 3
- Washington University School of Medicine, St Louis
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors
RekruterenFase 1/2
- WA Uni School Of Med, St Louis
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
RekruterenFase 1
- Washington University Medicine, St Louis
Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
RekruterenFase 1/2
- Washington University School of Medicine, St Louis
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RekruterenFase 3
- Mercy Clinic Oncology and Hematology Sindelar Cancer Center, St Louis
DSP-0390 in Combination With Atezolizumab for Small Cell Lung Cancer
RekruterenFase 1
- Washington University School of Medicine, St Louis
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RekruterenFase 1/2
- Washington University School of Medicine (Siteman Cancer Center), St Louis
A Study of LY4175408 in Participants With Advanced Cancer
RekruterenFase 1
- Washington University, St Louis
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
RekruterenFase 2
- Siteman Cancer Center, Washington University, St Louis
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
RekruterenFase 2
- Mercy Hospital South, St Louis
- Mercy Hospital Saint Louis, St Louis
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruterenFase 1/2
- Washington University, St Louis
JAB-2485 Activity in Adult Patients With Advanced Solid Tumors
RekruterenFase 1/2
- Washington University, St Louis
Kleincellige longkanker studies in andere steden
- Houston, TX26 studies
- Arlington, VA23 studies
- New York City, NY22 studies
- Boston, MA21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- Cleveland, OH13 studies
- Chicago, IL13 studies
- Detroit, MI12 studies
- Washington, DC12 studies
Andere studies in St. Louis
- Niet-kleincellige longkanker73 studies
- Borstkanker64 studies
- Metastatische kanker54 studies
- Colorectale kanker50 studies
- Kanker (alle vormen)46 studies
- Prostaatkanker46 studies
- Longkanker39 studies
- Eierstokkanker38 studies
- Aldermeesklierkanker33 studies
- Endometriumkanker29 studies
- Plaveiselcelcarcinoom van hoofd en hals28 studies
- Hartfalen26 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.